A refill logged one day past a Schedule III or IV prescription's six-month window, or a partial fill that pushes the cumulative quantity past what the prescriber authorized, is the kind of recordkeeping gap a DEA inspection is built to find. Schedule III, IV and V prescriptions sit inside the broader DEA audit defense landscape, and the refill, partial-fill and transfer rules at 21 CFR 1306.22, 1306.23 and 1306.25 are specific enough that a pharmacist-in-charge can check compliance against the regulation's own text.
The Five-Refill, Six-Month Limit for Schedule III and IV
Federal law caps how long and how often a Schedule III or IV prescription authorized for refills can be dispensed. Under 21 CFR 1306.22, such a prescription may not be refilled more than five times, and no refill may occur more than six months after the date the prescription was issued, regardless of how many of the five refills remain. Both limits run from the original issue date, not the date of the first fill, so a refill requested on day one of month seven fails the rule even if authorized refills remain unused.
Schedule V Carries No Federal Refill Cap
Section 1306.22 names only Schedule III and IV; it does not extend the five-refill, six-month limit to Schedule V. A Schedule V prescription's refills run on the prescriber's order, bounded by whatever limit the prescriber wrote and whatever additional limit state law imposes. The partial-filling and transfer provisions below apply to Schedule V exactly as they apply to Schedule III and IV, so a pharmacist-in-charge still has to document the authorization on file rather than assume a default refill count.
Partial Fills Run on the Same Clock
21 CFR 1306.23 permits partial filling of a Schedule III, IV or V prescription, but the practice is not a separate dispensing track. Each partial filling must be recorded in the same manner as a refilling, the total quantity dispensed across every partial filling cannot exceed the total quantity the prescriber authorized, and no dispensing can occur more than six months after the date the prescription was issued. A pharmacy that partial-fills a prescription across multiple installments still has one six-month window from the original issue date, not a fresh window from the first partial fill. A partial-fill log running past that window is a refill violation under the same regulation.
Transferring a Refill to Another Pharmacy
21 CFR 1306.25 governs when a pharmacy can send a Schedule III, IV or V prescription's refill information to another pharmacy. The default rule allows that transfer on a one-time basis only: once the information moves to a second pharmacy, it does not move again. The exception is narrow. Pharmacies that electronically share a real-time, online database may transfer up to the maximum number of refills permitted by law and authorized by the prescriber, not just once. Either way, the transfer must be communicated directly between two licensed pharmacists, and the transferring pharmacist must void the original prescription. The records each side produces on inspection are covered in Transferring Controlled Substance Prescriptions Between Pharmacies.
A Schedule III, IV or V prescription's refill information can move to a second pharmacy once. Absent a shared real-time database, it does not move again.
What a Refill or Transfer Error Signals on Inspection
A refill-count or dating error does not have to stay isolated to one prescription. DEA inspectors who find late partial fills, over-quantity dispensing, or a transfer handled outside 1306.25 can broaden the review into the pharmacy's inventory reconciliation records, since the same documentation gap can show up again in the controlled-substance count. The pharmacy can then face a DEA order to show cause seeking to revoke or suspend its registration, or, where the agency considers the risk urgent, an immediate suspension order that takes the registration offline before any hearing. Neither path turns on the medication's dollar value; both turn on whether the records show the rules were followed.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel once a DEA inspection or state board review raises a refill, partial-fill or transfer discrepancy. Early legal intervention can confirm which records the inspector is entitled to see and correct a documentation gap before it hardens into a formal finding. A pharmacy offered a Memoranda of Agreement With DEA should have counsel review the terms before signing anything.
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
Health Law Alliance's DEA defense attorneys review refill logs, partial-fill records and pharmacy transfers before an inspection finding becomes a registration action. If your pharmacy is facing a DEA inspection or a refill-documentation discrepancy, contact Health Law Alliance for a free, confidential consultation.





